William F. Doyle

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Portsmouth, NH
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Todd Girolamo, attorney in fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for William F. Doyle

Form 4 holding Executive Chairman, Director

NovoCure Ltd

Security class
Ordinary Shares
Shares / value
328,397
Estimated value
$4,409,977
Report date
03 Mar 2026
Price
$13.43
Ownership
Direct
Form 4 holding Director

Elanco Animal Health Inc

Security class
Common Stock
Shares / value
94,499
Estimated value
$1,403,291
Report date
29 Nov 2024
Price
$14.85
Ownership
Direct
Form 4 holding Executive Chairman, Director

NovoCure Ltd

Security class
Stock Option (Right to Buy)
Shares / value
288,517
Estimated value
Report date
03 Mar 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

PROKIDNEY CORP.

Security class
Director stock option (right to buy)
Shares / value
135,000
Estimated value
Report date
28 May 2026
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Minerva Neurosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
2,500
Estimated value
Report date
10 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by William F. Doyle

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .